These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 11451167)

  • 1. Genome-wide analyses on loss of heterozygosity in hepatocellular carcinoma in Southern China.
    Li SP; Wang HY; Li JQ; Zhang CQ; Feng QS; Huang P; Yu XJ; Huang LX; Liang QW; Zeng YX
    J Hepatol; 2001 Jun; 34(6):840-9. PubMed ID: 11451167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Genome-wide loss of heterozygosity analyses in primary hepatocellular carcinoma].
    Li S; Wang H; Zhang C
    Zhonghua Yi Xue Za Zhi; 2000 Aug; 80(8):577-81. PubMed ID: 11798820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive allelotype study of hepatocellular carcinoma: potential differences in pathways to hepatocellular carcinoma between hepatitis B virus-positive and -negative tumors.
    Okabe H; Ikai I; Matsuo K; Satoh S; Momoi H; Kamikawa T; Katsura N; Nishitai R; Takeyama O; Fukumoto M; Yamaoka Y
    Hepatology; 2000 May; 31(5):1073-9. PubMed ID: 10796882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological significance of loss of heterozygosity and microsatellite instability in hepatocellular carcinoma in China.
    Zhang SH; Cong WM; Xian ZH; Wu MC
    World J Gastroenterol; 2005 May; 11(20):3034-9. PubMed ID: 15918185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between loss of heterozygosity at microsatellite loci and computerized nuclear morphometry in hepatocellular carcinoma.
    Suzuki K; Hirooka Y; Tsujitani S; Yamane Y; Ikeguchi M; Kaibara N
    Anticancer Res; 2000; 20(2B):1257-62. PubMed ID: 10810431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic classification of combined hepatocellular-cholangiocarcinoma.
    Fujii H; Zhu XG; Matsumoto T; Inagaki M; Tokusashi Y; Miyokawa N; Fukusato T; Uekusa T; Takagaki T; Kadowaki N; Shirai T
    Hum Pathol; 2000 Sep; 31(9):1011-7. PubMed ID: 11014564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic changes and histopathological grades in human hepatocellular carcinomas.
    Konishi M; Kikuchi-Yanoshita R; Tanaka K; Sato C; Tsuruta K; Maeda Y; Koike M; Tanaka S; Nakamura Y; Hattori N
    Jpn J Cancer Res; 1993 Aug; 84(8):893-9. PubMed ID: 8407553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of heterozygosity at D8S298 is a predictor for long-term survival of patients with tumor-node-metastasis stage I of hepatocellular carcinoma.
    Pang JZ; Qin LX; Ren N; Hei ZY; Ye QH; Jia WD; Sun BS; Lin GL; Liu DY; Liu YK; Tang ZY
    Clin Cancer Res; 2007 Dec; 13(24):7363-9. PubMed ID: 18094418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletion of chromosomes 9p and 17 associated with abnormal expression of p53, p16/MTS1 and p15/MTS2 gene protein in hepatocellular carcinomas.
    Shao J; Li Y; Li H; Wu Q; Hou J; Liew C
    Chin Med J (Engl); 2000 Sep; 113(9):817-22. PubMed ID: 11776078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Relationship between microsatellite alterations on chromosome 8 and clinicopathological characteristics in hepatocellular carcinoma].
    Zhang SH; Cong WM; Xian ZH; Wu MC
    Zhonghua Bing Li Xue Za Zhi; 2004 Oct; 33(5):429-32. PubMed ID: 15498212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic alterations in hepatocellular carcinomas: association between loss of chromosome 4q and p53 gene mutations.
    Rashid A; Wang JS; Qian GS; Lu BX; Hamilton SR; Groopman JD
    Br J Cancer; 1999 Apr; 80(1-2):59-66. PubMed ID: 10389978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allelotype analysis of hepatocellular carcinoma.
    Piao Z; Park C; Park JH; Kim H
    Int J Cancer; 1998 Jan; 75(1):29-33. PubMed ID: 9426686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of cyclin D1, cyclin E, cdk4 and loss of heterozygosity of 8p, 13q, 17p in hepatocellular carcinoma: comparison study of childhood and adult hepatocellular carcinoma.
    Kim H; Lee MJ; Kim MR; Chung IP; Kim YM; Lee JY; Jang JJ
    Liver; 2000 Apr; 20(2):173-8. PubMed ID: 10847487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive allelotyping of human hepatocellular carcinoma.
    Nagai H; Pineau P; Tiollais P; Buendia MA; Dejean A
    Oncogene; 1997 Jun; 14(24):2927-33. PubMed ID: 9205099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide semiquantitative microsatellite analysis of human hepatocellular carcinoma: discrete mapping of smallest region of overlap of recurrent chromosomal gains and losses.
    Nishimura T; Nishida N; Komeda T; Fukuda Y; Ikai I; Yamaoka Y; Nakao K
    Cancer Genet Cytogenet; 2006 May; 167(1):57-65. PubMed ID: 16682288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of heterozygosity and microsatellite instability in hepatocellular carcinoma in Taiwan.
    Sheu JC; Lin YW; Chou HC; Huang GT; Lee HS; Lin YH; Huang SY; Chen CH; Wang JT; Lee PH; Lin JT; Lu FJ; Chen DS
    Br J Cancer; 1999 May; 80(3-4):468-76. PubMed ID: 10408855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequent loss of heterozygosity in two distinct regions, 8p23.1 and 8p22, in hepatocellular carcinoma.
    Lu T; Hano H; Meng C; Nagatsuma K; Chiba S; Ikegami M
    World J Gastroenterol; 2007 Feb; 13(7):1090-7. PubMed ID: 17373745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clonality analysis of multiple hepatocellular carcinomas by loss of heterozygosity pattern determined by chromosomes 16q and 13q.
    Lin YW; Lee HS; Chen CH; Huang GT; Lee PH; Sheu JC
    J Gastroenterol Hepatol; 2005 Apr; 20(4):536-46. PubMed ID: 15836701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Loss of heterozygosity of plasma circulating DNA from hepatocellular carcinoma patients and its clinical significance].
    Pang JZ; Qin LX; Wang QQ; Ren N; Sun BS; Lin GL; Ye QH; Liu YK; Tang ZY
    Zhonghua Gan Zang Bing Za Zhi; 2007 Dec; 15(12):906-9. PubMed ID: 18171524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association of frequent allelic loss on 17p13.1 with early metastatic recurrence of hepatocellular carcinoma after liver transplantation.
    Zhou L; Zhou W; Wu L; Yu X; Xing C; Zheng S
    J Surg Oncol; 2010 Dec; 102(7):802-8. PubMed ID: 20886556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.